| 1 |
Burlone ME, Minisini R, Pirisi M. Interferon-stimulated gene pathways in the treatment of viral hepatitis. Future Virology 2012;7:361-369. [DOI: 10.2217/fvl.12.21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 2 |
Im EH, Lee BS, Sung JK, Lee SO, Lee KT, Lee SM, Kim SH, Seo KS, Kim JH, Kim SG, Kim NJ, Lee HY. T cell subsets in chronic hepatitis B and the effect of prednisolone withdrawal and interferon alpha-2b. Korean J Intern Med 1999;14:1-8. [PMID: 10063307 DOI: 10.3904/kjim.1999.14.1.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 3 |
Podevin P, Guechot J, Serfaty L, Monrand-Joubert L, Veyrunes C, Bonnefis MT, Poupon R. Evidence for a deficiency of interferon response in mononuclear cells from hepatitis C viremic patients. J Hepatol 1997;27:265-71. [PMID: 9288599 DOI: 10.1016/s0168-8278(97)80170-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 4 |
Pirisi M, Fabris C, Toniutto P, Falleti E, Tisminetzky SG, Gerotto M, Soardo G, Vitulli D, Del Forno M, Baralle F, Bartoli E. Endogenous interferon-alpha concentration and outcome of interferon treatment in patients with chronic hepatitis C. Dig Dis Sci 1997;42:767-71. [PMID: 9125646 DOI: 10.1023/a:1018808012823] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 5 |
Sallie R. Hepatitis B virus replication and mutation are autoregulated by interactions between surface antigen and HBeAg and the HBV DNA polymerase: a functional model with therapeutic implications. Med Hypotheses 1997;48:1-10. [PMID: 9049982 DOI: 10.1016/s0306-9877(97)90016-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 6 |
Andreone P, Gramenzi A, Cursaro C, Felline F, Gasbarrini G, Bernardi M. Interaction Between Non Steroidal Antiinflammatory Drugs and Interferon-α System: Mechanisms and Basis for the Clinical Use in the Treatment of Chronic Viral Hepatitis. New Trends in Hepatology 1996. [DOI: 10.1007/978-94-009-0357-9_33] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 7 |
Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, Shiomi S, Seki S, Kobayashi K, Otani S. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995;346:1051-5. [PMID: 7564784 DOI: 10.1016/s0140-6736(95)91739-x] [Cited by in Crossref: 644] [Cited by in F6Publishing: 639] [Article Influence: 23.0] [Reference Citation Analysis]
|
| 8 |
Greenway AL, Hertzog PJ, Devenish RJ, Dudley FJ, McMullen GL, Linnane AW. Immunolocalisation of interferon-alpha in hepatitis C patients and its correlation with response to interferon-alpha therapy. J Hepatol 1994;21:842-52. [PMID: 7890902 DOI: 10.1016/s0168-8278(94)80248-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 9 |
Lok AS. Treatment of chronic hepatitis B. J Viral Hepat 1994;1:105-24. [PMID: 8790566 DOI: 10.1111/j.1365-2893.1994.tb00110.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 10 |
Thomas HC, Lok AS, Carreño V, Farrell G, Tanno H, Perez V, Dusheiko GM, Cooksley G, Ryff JC. Comparative study of three doses of interferon-alpha 2a in chronic active hepatitis B. The International Hepatitis Trial Group. J Viral Hepat 1994;1:139-48. [PMID: 8790569 DOI: 10.1111/j.1365-2893.1994.tb00113.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Fang JW, Wu PC, Lai CL, Lo CK, Meager A, Lau JY. Hepatic expression of interferon-alpha in chronic hepatitis B virus infection. Dig Dis Sci 1994;39:2014-21. [PMID: 8082512 DOI: 10.1007/BF02088140] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 12 |
Brandt ER, Devenish RJ, Hertzog PJ, Dudley FJ, Linnane AW. Detection of interferon-alpha expression by PCR in patients with chronic hepatitis C and hepatitis non-A, non-B. J Gastroenterol Hepatol 1994;9:373-80. [PMID: 7948820 DOI: 10.1111/j.1440-1746.1994.tb01258.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 13 |
Lau JY, Bird GL, Naoumov NV, Williams R. Hepatic HLA antigen display in chronic hepatitis B virus infection. Relation to hepatic expression of HBV genome/gene products and liver histology. Dig Dis Sci 1993;38:888-95. [PMID: 7683263 DOI: 10.1007/BF01295916] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 14 |
Towata T, Hayashi N, Katayama K, Takehara T, Miyoshi E, Kawanishi Y, Ueda K, Kasahara A, Fusamoto H, Kamada T. Effects of cytokines on HLA class I antigen expression on Huh6 and HB611 cells. Gastroenterol Jpn 1993;28:242-8. [PMID: 8387437 DOI: 10.1007/BF02779226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 15 |
Merritt JA, Ball LA, Sielaff KM, Meltzer DM, Borden EC. Modulation of 2',5'-oligoadenylate synthetase in patients treated with alpha-interferon: effects of dose, schedule, and route of administration. J Interferon Res 1992;Spec No:7-16. [PMID: 1640114 DOI: 10.1089/jir.1992.1992.7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 16 |
Villarrubia VG, Valladolid JM, Elorza FL, Sada G, Vilchez JG, Jimenez M, Herrerias JM. Therapeutic response of chronic active hepatitis B (CAHB) to a new immunomodulator: AM3. Immunohematological effects. Immunopharmacol Immunotoxicol 1992;14:141-64. [PMID: 1597653 DOI: 10.3109/08923979209009217] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 17 |
Sherker AH, Levy GA. New Therapeutic Strategies for Chronic Hepatitis. Modern Concepts in Gastroenterology Volume 3 1992. [DOI: 10.1007/978-1-4615-3314-6_14] [Reference Citation Analysis]
|
| 18 |
Lau JY, Alexander GJ, Alberti A. Viral hepatitis. Gut 1991;Suppl:S47-62. [PMID: 1916470 DOI: 10.1136/gut.32.suppl.s47] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 19 |
Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. Hepatology. 1991;13:364-375. [PMID: 1995444 DOI: 10.1002/hep.1840130226] [Cited by in Crossref: 266] [Cited by in F6Publishing: 246] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 20 |
Sylvan SP. Cellular immune responses to hepatitis B virus antigens in man. Liver 1991;11:1-23. [PMID: 1710754 DOI: 10.1111/j.1600-0676.1991.tb00485.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 21 |
Korba BE, Boumpas D, Mann D, Yoakum GH. Direct modulation of HBV surface antigen in a human, HBsAg-producing hepatocellular carcinoma cell line by alpha, beta, or gamma interferons. J Med Virol 1990;31:272-6. [PMID: 2176672 DOI: 10.1002/jmv.1890310406] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 22 |
Yoshioka K, Kakumu S, Arao M, Tsutsumi Y, Inoue M, Wakita T, Ishikawa T, Mizokami M. Immunohistochemical studies of intrahepatic tumour necrosis factor alpha in chronic liver disease. J Clin Pathol 1990;43:298-302. [PMID: 1692847 DOI: 10.1136/jcp.43.4.298] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 23 |
Hess G. Interferone bei chronischen Virushepatitiden. Interferone 1990. [DOI: 10.1007/978-3-642-93383-7_17] [Reference Citation Analysis]
|
| 24 |
Thomas HC. The hepatitis B virus and the host response. J Hepatol 1990;11 Suppl 1:S83-9. [PMID: 1706740 DOI: 10.1016/0168-8278(90)90170-v] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 25 |
Yoshioka K, Kakumu S, Arao M, Tsutsumi Y, Inoue M. Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology 1989;10:769-73. [PMID: 2553575 DOI: 10.1002/hep.1840100504] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 26 |
Ruiz-Moreno M, Camps T, Aguado JG, Porres JC, Oliva H, Bartolomé J, Carreño V. Serological and histological follow up of chronic hepatitis B infection. Arch Dis Child 1989;64:1165-9. [PMID: 2782931 DOI: 10.1136/adc.64.8.1165] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 27 |
Arao M, Kakumu S, Tahara H, Yoshioka K, Sakamoto N. Interferon alpha and gamma positive mononuclear cells and HLA antigen expression on hepatocyte membrane in the liver in chronic type B and non-A, non-B hepatitis. Gastroenterol Jpn 1989;24:255-61. [PMID: 2501137 DOI: 10.1007/BF02774322] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 28 |
Perrillo RP. Interferon therapy for chronic type B hepatitis: the promise comes of age. Gastroenterology 1989;96:532-5. [PMID: 2463207 DOI: 10.1016/0016-5085(89)91583-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 29 |
Escobar MR. Immunomodulation by Hepatitis B and Related Viruses. Virus-Induced Immunosuppression 1989. [DOI: 10.1007/978-1-4684-5583-0_2] [Reference Citation Analysis]
|
| 30 |
Alexander G. Treatment of acute and chronic viral hepatitis. Baillieres Clin Gastroenterol 1989;3:1-20. [PMID: 2655745 DOI: 10.1016/0950-3528(89)90043-2] [Reference Citation Analysis]
|
| 31 |
Wiedmann KH. Die Therapie der chronischen Virushepatitis — Ein noch ungelöstes Problem mit neuen Perspektiven. Therapeutische Probleme bei chronischen Lebererkrankungen 1989. [DOI: 10.1007/978-3-642-74671-0_2] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 32 |
Iraburu M, Civeira MP, Serrano M, Morte S, Castilla A, Prieto J. Suppressor T-cell activity in chronic hepatitis B-virus infection: relationship with the presence of HBV-DNA in serum. J Med Virol 1989;27:39-43. [PMID: 2522145 DOI: 10.1002/jmv.1890270109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 33 |
Ogawa Y. 2',5'-Oligoadenylate synthetase activity in the liver and peripheral blood mononuclear cells of chronic hepatitis patients. Gastroenterol Jpn 1988;23:279-86. [PMID: 2456963 DOI: 10.1007/BF02779471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 34 |
Zachoval R, Abb J, Zachoval V, Eisenburg J, Pape GR, Paumgartner G, Deinhardt F. Interferon alpha in hepatitis type B and non-A, non-B. Defective production by peripheral blood mononuclear cells in chronic infection and development of serum interferon in acute disease. J Hepatol 1988;6:364-8. [PMID: 3134484 DOI: 10.1016/s0168-8278(88)80055-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 35 |
Hirai N, Shimizu M, Morioka T, Hinoue Y, Tanaka N, Kobayashi K, Hattori N, Hashimoto T. Activities of the interferon system in patients with HBsAg-positive chronic hepatitis B during short-term steroid withdrawal therapy. Liver 1988;8:138-45. [PMID: 3393063 DOI: 10.1111/j.1600-0676.1988.tb00982.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 36 |
Lever AM. Treatment of the chronic hepatitis B virus carrier state. J Infect 1988;16:221-9. [PMID: 2456355 DOI: 10.1016/s0163-4453(88)97508-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 37 |
Paronetto F. The Role of the Reticuloendothelial System in Viral Hepatitis. Infection 1988. [DOI: 10.1007/978-1-4899-3748-3_11] [Reference Citation Analysis]
|
| 38 |
Müller R, Klein H, Niehoff G. Virostatische Therapie der chronischen Hepatitis. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1988. [DOI: 10.1007/978-3-642-85461-3_63] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 39 |
Civeira M, Prieto J, Morte S, Riñon M, Serrano M. Interleukins in chronic active hepatitis B. Relationship with viral markers. J Hepatol 1987;5:37-44. [PMID: 3498750 DOI: 10.1016/s0168-8278(87)80059-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 40 |
Fuji A, Kakumu S, Ohtani Y, Murase K, Hirofuji H, Tahara H. Interferon-gamma production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology 1987;7:577-81. [PMID: 3106184 DOI: 10.1002/hep.1840070327] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 41 |
Matsushita K, Arima T, Nagashima H. In vitro interferon producing activity of peripheral mononuclear cells in patients with chronic liver disease. Gastroenterol Jpn 1987;22:166-73. [PMID: 3036638 DOI: 10.1007/BF02774213] [Reference Citation Analysis]
|
| 42 |
Cady B. Primary hepatobiliary carcinoma. Cancer Treatment and Research 1987. [DOI: 10.1007/978-1-4613-2031-9_11] [Reference Citation Analysis]
|
| 43 |
Thomas HC, Scully LJ, Lever AM, Yap I, Pignatelli M. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates. Infection 1987;15 Suppl 1:S26-31. [PMID: 2439462 DOI: 10.1007/BF01650108] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 44 |
Ikeda T, Lever AM, Thomas HC. Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life. Hepatology 1986;6:962-5. [PMID: 2428724 DOI: 10.1002/hep.1840060525] [Cited by in Crossref: 105] [Cited by in F6Publishing: 106] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 45 |
Davis GL, Hoofnagle JH. Interferon in viral hepatitis: role in pathogenesis and treatment. Hepatology 1986;6:1038-41. [PMID: 2428722 DOI: 10.1002/hep.1840060537] [Cited by in Crossref: 103] [Cited by in F6Publishing: 94] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 46 |
Jilbert AR, Burrell CJ, Gowans EJ, Hertzog PJ, Linnane AW, Marmion BP. Cellular localization of alpha-interferon in hepatitis B virus-infected liver tissue. Hepatology 1986;6:957-61. [PMID: 3530948 DOI: 10.1002/hep.1840060524] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 47 |
Stefanini GF, Mazzetti M, Zunarelli P, Baraldini M, Pignatelli M, Canonica GW, Miglio F, Gasbarrini G. T lymphocyte subsets implicated in cytotoxicity in autologous hepatocytes in chronic active hepatitis patients with active viral replication. Clin Immunol Immunopathol 1986;40:214-23. [PMID: 3487403 DOI: 10.1016/0090-1229(86)90024-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 48 |
Merritt JA, Ball LA, Sielaff KM, Meltzer DM, Borden EC. Modulation of 2',5'-oligoadenylate synthetase in patients treated with alpha-interferon: effects of dose, schedule, and route of administration. J Interferon Res 1986;6:189-98. [PMID: 3745984 DOI: 10.1089/jir.1986.6.189] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 49 |
Eddleston A. Interferons in the treatment of chronic hepatitis B virus infection. Med Clin North Am 1986;Suppl:25-30. [PMID: 3090382 DOI: 10.1016/s0025-7125(16)36784-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 50 |
Jilbert AR, Hertzog PJ, Burrell CJ, Gowans EJ, Linnane AW, Marmion BP. Production of a monoclonal antibody to human interferon-alpha (IFN-alpha) and its use to identify IFN-alpha-producing cells in virus infection in vivo. Microb Pathog 1986;1:159-68. [PMID: 3508487 DOI: 10.1016/0882-4010(86)90018-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 51 |
Jicha DL, Davis GL, Peters MG, Hoofnagle JH, Jones EA. Effects of recombinant human leukocyte interferon treatment of endogenous interferon production in patients with chronic type-B hepatitis. J Interferon Res 1986;6:13-20. [PMID: 3084673 DOI: 10.1089/jir.1986.6.13] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 52 |
Thomas HC, Scully LJ, Lever AML, Yap I, Pignatelli M. A Review of the Efficacy of Adenine Arabinoside and Lymphoblastoid Interferon in the Royal Free Hospital Studies of Hepatitis B Virus Carrier Treatment: Identification of Factors Influencing Response Rates. Proceedings in Life Sciences 1986. [DOI: 10.1007/978-3-642-71350-7_9] [Reference Citation Analysis]
|
| 53 |
Scully LJ, Lever AM, Yap I, Pignatelli M, Thomas HC. Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection. A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies. J Hepatol 1986;3 Suppl 2:S291-9. [PMID: 2439575 DOI: 10.1016/s0168-8278(86)80134-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 54 |
Abb J, Zachoval R, Eisenburg J, Pape GR, Zachoval V, Deinhardt F. Production of interferon alpha and interferon gamma by peripheral blood leukocytes from patients with chronic hepatitis B virus infection. J Med Virol 1985;16:171-6. [PMID: 3925078 DOI: 10.1002/jmv.1890160209] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 55 |
Poitrine A, Chousterman S, Chousterman M, Naveau S, Thang MN, Chaput JC. Lack of in vivo activation of the interferon system in HBsAg-positive chronic active hepatitis. Hepatology 1985;5:171-4. [PMID: 2579880 DOI: 10.1002/hep.1840050202] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 56 |
Vanĕcek K, Lehovcová A. Interferon production in children with respiratory diseases. Acta Paediatr Scand 1985;74:118-21. [PMID: 3984715 DOI: 10.1111/j.1651-2227.1985.tb10931.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 57 |
Matricardi PM, Capobianchi MR, Paganelli R, Facchini J, Sirianni MC, Seminara R, Dianzani F, Aiuti F. Interferon production in primary immunodeficiencies. J Clin Immunol 1984;4:388-94. [PMID: 6092414 DOI: 10.1007/BF00917142] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.3] [Reference Citation Analysis]
|
